(ABVC) ABVC Biopharma - Performance 10% in 12m
Compare ABVC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-82.72%
#153 in Group
Rel. Strength
34.31%
#5227 in Universe
Total Return 12m
10.00%
#55 in Group
Total Return 5y
-95.97%
#149 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -10.11%
(?) Percentile in Group
12m Total Return: ABVC (10%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ABVC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABVC
| Total Return (including Dividends) | ABVC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 23.47% | 2.02% | 2.87% |
| 3 Months | 188.03% | -15.44% | -6.42% |
| 12 Months | 10.00% | -14.02% | 9.87% |
| 5 Years | -95.97% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | ABVC | XBI | S&P 500 |
| 1 Month | 74.5% | 57% | 89.4% |
| 3 Months | 86.6% | -82.3% | -72% |
| 12 Months | -21.3% | -53.1% | 49.3% |
| 5 Years | -95.3% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #147 | 21.0% | 20.0% |
| 3 Month | #4 | 241% | 208% |
| 12 Month | #55 | 27.9% | 0.12% |
| 5 Years | #154 | -94.6% | -98.1% |
FAQs
Does ABVC ABVC Biopharma outperforms the market?
Yes,
over the last 12 months ABVC made 10.00%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months ABVC made 188.03%, while XBI made -15.44%.
Over the last 3 months ABVC made 188.03%, while XBI made -15.44%.
Performance Comparison ABVC vs Indeces and Sectors
ABVC vs. Indices ABVC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 15.7% | 20.6% | 135% | 0.13% |
| US NASDAQ 100 | QQQ | 15.4% | 18.8% | 135% | -1.32% |
| US Dow Jones Industrial 30 | DIA | 15.4% | 21.9% | 136% | 3.63% |
| German DAX 40 | DAX | 13.6% | 4.19% | 110% | -15.1% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 15.0% | 17.2% | 136% | 4.37% |
| Hongkong Hang Seng | HSI | 12.2% | 7.26% | 126% | -2.09% |
| India NIFTY 50 | INDA | 18.1% | 21.2% | 133% | 7.67% |
| Brasil Bovespa | EWZ | 13.6% | 11.9% | 126% | 16.5% |
ABVC vs. Sectors ABVC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 15.5% | 19.8% | 129% | -10.3% |
| Consumer Discretionary | XLY | 14.8% | 20.0% | 137% | -4.05% |
| Consumer Staples | XLP | 16.0% | 21.5% | 128% | 2.44% |
| Energy | XLE | 14.7% | 23.4% | 141% | 19.8% |
| Financial | XLF | 15.0% | 17.9% | 129% | -11.5% |
| Health Care | XLV | 19.5% | 27.9% | 140% | 15.9% |
| Industrial | XLI | 14.1% | 16.1% | 134% | 0.01% |
| Materials | XLB | 15.7% | 18.8% | 139% | 16.0% |
| Real Estate | XLRE | 16.0% | 17.4% | 133% | -3.46% |
| Technology | XLK | 14.8% | 16.7% | 137% | 3.0% |
| Utilities | XLU | 14.6% | 17.9% | 127% | -5.91% |
| Aerospace & Defense | XAR | 15.2% | 14.1% | 126% | -15.2% |
| Biotech | XBI | 23.8% | 21.5% | 156% | 24.0% |
| Homebuilder | XHB | 16.1% | 20.4% | 149% | 19.8% |
| Retail | XRT | 15.5% | 19.9% | 141% | 14.3% |